News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ELTP: Fibonacci Targets using the Fibonacci Arc as well as mathematical calculations for confirmation.
Click on image to enlarge.
As we embark on this incredible journey with ELTP, the chart with critical price points becomes more relevant.
As you know, the target of 1.33/1.34 has been noted here on several occasions, but we don't know when we will hit that number, or what the resistance points should be until now...at least that is the hope.
What we do know is that .97 is our most recent all time high; I have pegged .1201 as a bottom point of that rise. If you note, .97 / by .1201 is '8'. Let it be also noted that a calculation of .20 X '8' is 1.60, our target for the Fib #1.62, referred to as the 'golden ratio'.
From .97 (or .9703) I will use Fibonacci #s to target stops along the way to our ultimate (at this time) $2 (100%).
.9703 X 1.08 = 1.05;
.9703 X 1.382 = 1.34;
.9703 X 1.5 = 1.455;
.9703 X 1.618 = 1.57;
.9703 X 2 = 1.9406.
There is no warranty as to the accuracy, real or implied, of this information.
VICL: June 12 Two Years Daily Chart.
Technical Indicators on 6 months chart
Click to enlarge image.
No warranties of accuracy is implied.
Thank you ash111 for the following:
'VICL, more info: HCW starts Vical at buy : June 12, 2015 by leonardzehr
buy4H.C. Wainwright has launched coverage of Vical (NASDAQ:VICL) with a “buy” rating and a target price of $2.50, based on a discounted revenue and earnings valuation methodology. The stock closed at $1.47 on Thursday.
Vical’s core franchise is comprised of a broadly applicable vaccine technology platform and is developing ASP0113 to address cytomegalovirus infections, a serious unmet need in immunosuppressed hematopoietic stem cell transplant and solid organ transplant patients.
“In our view, these two markets combined address a $1.8-billion opportunity and represent low hanging fruit in terms of clinical and regulatory success,” writes analyst Mark Breidenbach.
In addition, Phase 2 data from Vical’s Herpes Simplex Virus vaccine program is expected imminently, he added.
Mr. Breidenbach said that with a newly licensed anti-fungal asset, Astellas as a Big Pharma partner, and a cash position of approximately $46.3-million, which should be sufficient to fund operations into 2017, “we believe Vical represents an under appreciated story with potential upside for long-term, risk-oriented investors.”
biotuesdays.com/2015/06/12/hcw-starts-vical-at-buy/ '
TPIV: More, Eagle1...A sight to behold June 12 (just a bit different perspective re data):
Click on image to enlarge.
LIBE 30 mins chart; a penny stock I just came across. Should be good for flippers. Looks like .0009 will be your jump off point.
30M+ volume at its high.
Click on image to enlarge.
Not intended as an inducement to buy or sell; no warranty of accuracy accompanies this information.
CPXX...Today's six month chart w/rsi, macd and Donchian Channels. Looks like it is getting ready to run on a Wave 5
(Elliott Wave Theory) to about 3.56:
Click on image to enlarge.
Not intended as an inducement to buy or sell; and no implied warranties of accuracy accompany this information.
TPIV: One year chart w/RSI and MACD, Donchian Channels:
Click on image to enlarge.
No warranties of accuracy are implied, no inducements to buy or sell.
FRO
and SVON...
Click on image to enlarge.
There is no warranty of results; no inducement to buy or sell.
IB: FRO chart June 11:
Click on image to enlarge.
TPIV chart June 11 support lines drawn for eagle1:
200 DMA @.7793 and price is now below.
Click on image to enlarge.
I am going to be watching TPIV. Thank you!
Also, another one that just took a little sprint and may be up your alley, MDCN but I think it will come back down to .0010. Let me know if you want me to watch and send you an alert.
I deserved that Eagle1. GLARING error! Let that be a lesson to me as I begin this public journey. I hope you will allow me to make up for that, but if not I do wish you success always. My motto: I break it; I own it. BTW, did you see out little ELTP at long last begin its (hopefully second huge triumphant win since March 2014?)
Congratulations on TPIV 'American Pharoah' finish.
Sharpei Diem!...You, too can learn to determine price direction without having to struggle through numerous online studies. |
'Keep It Simple Stupid' in the Complicated World of Stock Trading and Investment.
Thinking about where to best get in or out of your targeted stock? When you doubt where to put in a 'buy' order, go for the lower price even if means waiting -and you are chomping at the bit . Fibonacci numbers are most helpful as are technical indicators: moving averages, long term as well as short term chart assessments, Elliott Wave, rsi, macd, slow stochastics, adx/dmi, Donchian Channels, etc. in conjunction with Fundamentals to include the latest Q's, paying particular care to net assets.
(When considering small caps, I tend to pay particular attention to and avoid those that show reserves out of balance when compared to future requirements to operate, low floats, possible bk or 'lawsuits' mentioned on message boards and heavy finger-pointing at management found on message boards. (This last can be unreliable if there is an unusually high complement of postings of questionable or malicious intent.)
| Some believe technical analysis works, while others feel it's akin to reading tea leaves. Judging by the feedback comments on this column, reader opinions are sharply divided too. The fundamental analysts who didn't see the fall in the oil price, or who told us that gold was going back to $1,500, or that the DOW would collapse didn't seem to attract as much trenchant criticism as those of us involved in technical analysis. In 2014 we produced weekly CNBC blogs providing trading outlooks based on technical and chart analysis. We use chart analysis to establish the probability of trend change and to set price targets and objectives. In 88 percent of analysis notes in 2014 the price targets were achieved or exceeded. That's around the same percentage of correct calls in 2013 and 2012. The analysis methods we use are not complex; they can be applied by anyone without the need for a Master's degree in finance. These methods are covered in my books, including Guppy Trading. Charting analysis provides both the calculated price targets and the price levels that indicate the trade has failed. In 12 percent of cases, the analysis is not correct, but chart analysis provides exact price levels that signal this decision in real time.  Our best calls for 2014 included the January 2013 DOW target of 17,000, NASDAQ at 4600 and S&P at 2000. They also included oil at $88, and then later $68 and $58. The next downside support target for NYMEX oil is $48. Gold support near $1,180 and the Shanghai Index upside targets above 3000 were also other correct analysis calls. Our worst call was the NIFTY where we expected the parabolic trend to develop into a 50 percent or greater retracement. There was a correction, but it was not a major change in the trend. Two bullish calls on the Australian dollar were also incorrect, with the market failing to break through resistance levels. Chart analysis is designed to identify situations where high probability outcomes are expected. Often chart analysis can be used to set exact price targets. The CNBC notes apply the same analysis methods we use in our personal trading and we use them because they work. Daryl Guppy Contributor This site is not intended to be a full course of study as there would be no time to process members' charts and questions, but there will be an attempt to encapsulate the oft-asked critical issues with TA as they apply to most of you. For more in depth study I have noted above under 'Author's Sources' and highlighted text quality sites that can be accessed online. (If you have a particular question regarding the action of an indicator or related to this process, just post it and I will answer to the best of my ability. Thanks for your patience with the limitations of this site. Using Technical Indicators The following is a short cut to finding an entry point but if you use most or all these 'tests' before jumping in, you should have some protection from overpaying a stock. (It is imperative that you use these in conjunction with the following time charts: Weekly one year, two year, five year, twenty (not all necessarily but use about three); AND. also do the same with the daily _ and even take a look at a couple of monthly charts (one to twenty years depending on how long its been listed, of course); then the final critical data to cement your decision should come from very short term - from six months daily to 60, 30, 10, 05 mins (in multiple time frames - two to 20 days, for example). Moving Averages: 50 DMA... Does this support a current price or are you looking forward to resistance at this MA? Same with 200 DMA. It's a happy chart that shows an upward cross over the 200 DMA by the 50. Use these in conjunction with the other Tech Indicators.
***Notice: I would like to welcome aboard one other chartist, Conix from the IHUB family of contributors. He, too will be adding his expertise in this area to those who wish help in their investment choices and approaches. Rules of Investing 1-10 are Keep It Simple Stupid X 10.  |
AI
